Adalimumab (Humira�) is the third TNF antagonist (after infliximab and etanercept) to be approved in the US. Like infliximab and etanercept, adalimumab binds to TNFα, preventing it from activating TNF receptors; adalimumab was constructed from a fully human monoclonal antibody, while infliximab is a mouse-human chim... more at Wikipedia

It took away my hand movement problems, but, because it lowers one's immune system, I believe it was a factor in contracting a very painful case of Shingles. The immunity side effect in general bothered me.

Content on DailyStrength.org is for informational purposes only. We do not provide any medical advice, diagnosis or treatment.
More infoPortions of support group and treatment information provided by Wikipedia under the GNU FDL license